Cannabidiol (CBD) has tremendous therapeutic potential, but its development as an effective drug for the pharmaceutical industry is hampered by intrinsic properties such as low bioavailability, low aqueous solubility, and variable pharmacokinetic profiles. Potential avenues to overcome these issues for CBD include self-emulsifying drug delivery systems, improved crystalline formulations, and other solid-state delivery formulations, most […]
